- Home
- ATO vs TEVA Comparison
ATO vs TEVA Comparison
Compare ATO & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATO
- TEVA
- Stock Information
- Founded
- ATO 1906
- TEVA 1901
- Country
- ATO United States
- TEVA Israel
- Employees
- ATO N/A
- TEVA N/A
- Industry
- ATO Oil/Gas Transmission
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- ATO Utilities
- TEVA Health Care
- Exchange
- ATO Nasdaq
- TEVA Nasdaq
- Market Cap
- ATO 24.4B
- TEVA 20.1B
- IPO Year
- ATO 1987
- TEVA N/A
- Fundamental
- Price
- ATO $154.86
- TEVA $16.41
- Analyst Decision
- ATO Buy
- TEVA Strong Buy
- Analyst Count
- ATO 9
- TEVA 7
- Target Price
- ATO $157.94
- TEVA $24.71
- AVG Volume (30 Days)
- ATO 742.0K
- TEVA 10.0M
- Earning Date
- ATO 08-06-2025
- TEVA 07-30-2025
- Dividend Yield
- ATO 2.25%
- TEVA N/A
- EPS Growth
- ATO 8.10
- TEVA N/A
- EPS
- ATO 7.25
- TEVA N/A
- Revenue
- ATO $4,485,994,000.00
- TEVA $16,616,000,000.00
- Revenue This Year
- ATO $13.27
- TEVA $5.69
- Revenue Next Year
- ATO $12.93
- TEVA N/A
- P/E Ratio
- ATO $21.31
- TEVA N/A
- Revenue Growth
- ATO 10.60
- TEVA 3.82
- 52 Week Low
- ATO $117.78
- TEVA $12.47
- 52 Week High
- ATO $167.45
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- ATO 50.18
- TEVA 41.31
- Support Level
- ATO $150.51
- TEVA $16.55
- Resistance Level
- ATO $154.73
- TEVA $17.07
- Average True Range (ATR)
- ATO 2.16
- TEVA 0.37
- MACD
- ATO 0.16
- TEVA -0.08
- Stochastic Oscillator
- ATO 51.69
- TEVA 9.29
About ATO Atmos Energy Corporation
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.